• Science Applications International Corp. has recently secured a US$95 million contract from the U.S. Government Accountability Office to modernize its Technical Information Services program with end-to-end IT solutions and a more secure, data-driven infrastructure.
• By embedding security, automation, and agile delivery into GAO’s technology stack, SAIC is positioning itself as a key partner in federal IT modernization and complex digital engineering projects.
• Next, we’ll examine how this GAO win, with its emphasis on large-scale IT modernization, may influence SAIC’s existing investment narrative.

Rare earth metals are the new gold rush. Find out which 31 stocks are leading the charge.

Science Applications International Investment Narrative Recap

To own SAIC, you need to believe it can offset slow, government driven revenue with disciplined execution, higher value IT modernization work, and solid cash generation. The new US$95 million GAO contract supports the modernization and digital engineering catalyst, but it does not fundamentally change the near term risk that budget constraints and funding delays could prolong weak top line growth and heighten competition for federal IT awards.

Among recent developments, the formation of the Alliance for Advancing Rural Healthcare looks most connected to this GAO win, as both center on modern, secure, data driven solutions for complex public sector missions. Together, they highlight SAIC’s push toward differentiated digital modernization capabilities, a key potential offset to pressures on traditional, labor based IT contracts and one of the more important catalysts investors are watching.

Yet even as SAIC wins modernization work, investors should be aware that growing reliance on government IT budgets could...

Science Applications International's narrative projects $7.7 billion revenue and $344.8 million earnings by 2028. This requires 1.0% yearly revenue growth and an earnings decrease of $54.2 million from $399.0 million today.

Uncover how Science Applications International's forecasts yield a $113.38 fair value, a 23% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were expecting SAIC to reach about US$8.5 billion in revenue and roughly US$439 million in earnings by 2028, which is a much brighter scenario than the consensus view of low growth and earnings pressure. Depending on how you see the new GAO contract and broader digital transformation momentum, you may lean toward that upbeat outlook or stay closer to the cautious narrative, so it is worth comparing these very different expectations before you decide where you stand.

Explore 4 other fair value estimates on Science Applications International - why the stock might be worth just $94.71!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Science Applications International research is our analysis highlighting 5 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Science Applications International research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Science Applications International's overall financial health at a glance.

Seeking Other Investments?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• AI is about to change healthcare. These 27 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Outshine the giants: these 22 early-stage AI stocks could fund your retirement.
• We've uncovered the 13 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.